Biomagnetics Diagnos (BMGP) 0.0007 $BMGP Delving into

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Biomagnetics Diagnos (BMGP) 0.0007 $BMGP

Delving into Stem Cell Research and its Potential: 2015 Study
M2 - Mon Jun 29, 10:11AM CDT
Research and Markets (http://www.researchandmarkets.com/research/f9rhn9/delving_into_stem) has announced the addition of the "Delving into Stem Cell Research and its Potential" report to their offering. Stem cells are primal cells found in all multi-cellular organisms that retain the ability to renew themselves through mitotic cell division and can differentiate into a wide range of specialized cell types. As stem cells can be readily grown and transformed into specialized cells with characteristics consistent with cells of various tissues such as muscles or nerves through cell culture, their use in medical therapies has been proposed. In particular, embryonic cell lines, autologous embryonic stem cells generated through therapeutic cloning, and highly plastic adult stem cells from the umbilical cord blood or bone marrow are touted as promising candidates. There exists a widespread controversy over stem cell research that emanates from the techniques used in the creation and usage of stem cells. Human embryonic stem cell research is particularly controversial because, with the present state of technology, starting a stem cell line requires the destruction of a human embryo and/or therapeutic cloning. This research brings you an entire in-depth study of a very niche subject in the wide field of stem cells - Stem Cell Research and its Potential. The report looks at the various types of stem cells which exist and the different benefits each of them offer. The much-talked about embryonic stem cell research and adult stem cell research is discussed in-depth in the report. A separate section covers all the medical uses of stem cell research as well as exploring the potential of stem cell research and therapies. Challenges, barriers, benefits of stem cells, a look at the global approach to stem cell research, and an analysis of the leading players in this industry are what make this report a must-have! Key Topics Covered: A. Executive Summary B. Introduction to Stem Cells C. Looking into Stem Cell Research D. Potential of Stem Cell Research & Therapies E. Benefits of Stem Cell Therapies F. Barriers & Challenges in Stem Cell Research G. Stem Cell in Medical Use H. Trends in the Industry I. Funding for Stem Cell Research J. Global Approach to Human Stem Cell Research K. Industry Outlook L. Leading Players in Stem Cell Research M. Appendix N. Glossary of Terms Companies Mentioned - Amgen - Apceth Gmbh & Co. Kg - Athersys - Bioheart, Inc. - Biomagnetics Diagnostics Corporation - BioTime, Inc. - Brainstorm Cell Therapeutics Inc - Caladrius Biosciences Inc - Celera Corporation (Quest Diagnostics) - Cesca Therapeutics - Cryo-Cell International - CytoGenix, Inc. - Cytori Therapeutics Inc - Gamida Cell Ltd. - Geron Corporation - International Stem Cell Corporation (ISCO) - Microchip Technology Inc. - Neuralstem, Inc. - Ocata Therapeutics - Osiris Therapeutics, Inc. - StemCells Inc - Tigenix NV - Transition Therapeutics Inc. - Vericel Corporation For more information visit http://www.researchandmarkets.com/research/f9..._into_stem
KOOL: 2.92 (+0.03), OCAT: 8.47 (+0.01), VCEL: 2.23 (-0.06), MCHP: 51.91 (+0.04), TTHI: 0.78 (+0.02), OSIR: 5.17 (+0.02), AMGN: 149.42 (-1.23), CLBS: 0.49 (unch), BCLI: 2.39 (+0.02), CYTX: 2.07 (-0.05), GERN: 2.68 (-0.12), DGX: 77.87 (+0.03), CUR: 0.32 (unch)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Evaluating Planet Labs' Stock Surge: Is It Still Worth Buying?

Updated Category News Views 92

Planet Labs Stock Soars: A Close Look The stock has experienced remarkable growth this year, surging by 340% year-to-date. An impressive 37% increase occurred in just one day, showcasing investor enthusiasm following a strong earnings report. Planet Labs was trading at around $3.97 per share at the start of 2025. Fast forward almost a year, and the stock has climbed to...

Continue Reading
Capricor Therapeutics: Important Class Action Details to Know

Updated Category News Views 188

Understanding the Class Action Lawsuit Against Capricor Therapeutics It is crucial for investors of Capricor Therapeutics, Inc. to stay updated regarding the ongoing class action lawsuit. If you have invested in the company's securities within the established timeframe, you may have a valid claim to pursue compensation. Key Dates and Deadlines Investors who purchased...

Continue Reading
Unforgettable Wines from Friuli Venezia Giulia Showcase

Updated Category News Views 136

Experience the Wines of Friuli Venezia Giulia in New York An incredible showcase awaits wine lovers as the Wines of Friuli Venezia Giulia make a spectacular debut on the vibrant streets of New York City. This immersive tasting experience brings together the renowned wine producers from one of Italy's most influential wine regions, allowing guests to appreciate the unique...

Continue Reading
Why Energy Fuels ($UUUU) Is a Stellar Long-Term Bet

Updated Category News Views 166

Let’s Talk Energy Fuels and Its Decade-Long Ride Alright, folks, grab a cup of coffee and buckle up because we’re diving into Energy Fuels (AMEX:UUUU) like a hawk diving on a field mouse. This is the kind of stock that if you’d thrown down a grand ten years ago, it’d be worth a jaw-dropping $8,394.74 now—yeah, you heard me right! It’s been producing an average...

Continue Reading
Purpose Investments Inc. Reveals Monthly Distributions for ETFs

Updated Category News Views 72

Monthly Distribution Announcement by Purpose Investments PURPOSE INVESTMENTS INC. is excited to share the distributions scheduled for October across its open-end exchange traded funds and closed-end funds. The upcoming disbursements aim to provide transparency to investors and stakeholders, informing them about the financial performance and expected returns of the Funds....

Continue Reading